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Summary
Ecotin is a potent inhibitor of family S1A serine
peptidases, enzymes lacking in the protozoan
parasite Leishmania major. Nevertheless, L. major
has three ecotin-like genes, termed inhibitor of
serine peptidase (ISP). ISP1 is expressed in vector-
borne procyclic and metacyclic promastigotes,
whereas ISP2 is also expressed in the mammalian
amastigote stage. Recombinant ISP2 inhibited
neutrophil elastase, trypsin and chymotrypsin with
Kis between 7.7 and 83 nM. L. major ISP2–ISP3
double null mutants (Disp2/3) were created. These
grew normally as promastigotes, but were inter-
nalized by macrophages more efficiently than
wild-type parasites due to the upregulation of
phagocytosis by a mechanism dependent on
serine peptidase activity. Disp2/3 promastigotes
transformed to amastigotes, but failed to divide
for 48 h. Intracellular multiplication of Disp2/3
was similar to wild-type parasites when serine
peptidase inhibitors were present, suggesting that
defective intracellular growth results from the lack
of serine peptidase inhibition during promastigote
uptake. Disp2/3 mutants were more infective than
wild-type parasites to BALB/c mice at the early
stages of infection, but became equivalent as the
infection progressed. These data support the
hypothesis that ISPs of L. major target host serine
peptidases and inﬂuence the early stages of infec-
tion of the mammalian host.
Introduction
Leishmania are trypanosomatid parasitic protozoa that
cause a spectrum of human diseases, the leishmaniases,
ranging from a lethal visceral infection to milder cutaneous
ulcers. Their life cycle involves a ﬂagellated procyclic pro-
mastigote stage that multiplies in the sandﬂy gut, a non-
dividing ﬂagellated metacyclic promastigote stage within
the sandﬂy mouth parts, and a non-motile amastigote form
that proliferates in mammalian macrophages. Peptidases
play important roles in the pathogenicity of many parasitic
protozoa, including Leishmania (Sajid and McKerrow,
2002; Mottram et al., 2004). The genome of Leishmania
major, one of the causative agents of cutaneous leishma-
niasis in the Old World, has been sequenced (Ivens et al.,
2005), revealing the presence of at least 153 identiﬁable
peptidases that can be classiﬁed into the major catalytic
types(cysteine-,serine-,metallo-,threonineandaspartic-)
and represent ~2% of the genome. One of the major
mechanisms used to control the activity of peptidases in
mammalsisatightinteractionwithnaturalpeptidaseinhibi-
tors such as serpins, cystatins and tissue inhibitor of
metalloproteinases (Rawlings et al., 2004). The L. major
genome does not appear to contain any orthologues of
these molecules, yet it is not devoid of natural peptidase
inhibitors (Ivens et al., 2005). The ﬁrst to be identiﬁed in L.
major was an inhibitor of cysteine peptidases (ICP), which
is a member of the chagasin family of inhibitors ﬁrst iden-
tiﬁed in Trypanosoma cruzi (Monteiro et al., 2001) and
subsequently found in a variety of bacterial and protozoan
pathogens(Rigdenet al.,2002;Sandersonet al.,2003).In
T. cruzi and Trypanosoma brucei chagasin/ICP is a modu-
lator of parasite differentiation (Santos et al., 2005; 2007),
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cellular microbiologywhile L. major ICP is thought to play a role in the host–
parasite interaction (Besteiro et al., 2004). L. major ICP
and T. cruzi chagasin have an unusual immunoglobulin-
like fold with a cystatin-like mechanism of inhibition, which
distinguishes them from all other known peptidase inhibi-
tors (Salmon et al., 2006; Smith et al., 2006).
A second group of putative peptidase inhibitors identi-
ﬁed in the L. major genome are orthologues of the
Escherichia coli serine peptidase (SP) inhibitor ecotin and
have been termed inhibitor of serine peptidases (ISPs).
Ecotin is an 18 kDa protein ﬁrst isolated from the peri-
plasm of E. coli (Chung et al., 1983). It forms dimers and
inhibits a wide range of SPs from the S1A peptidase
family (trypsin fold) of clan PA(S), which includes trypsin,
chymotrypsin, neutrophil elastase (NE) and cathepsin G
(Chung et al., 1983; McGrath et al., 1995). There are no
reports that ecotin inhibits SPs of other families or cata-
lytic classes. In addition, Chung et al. (1983) were unable
to identify an E. coli peptidase sensitive to ecotin, sug-
gesting that ecotin may protect the cell against exogenous
S1A peptidases (Eggers et al., 2004), which are involved
in processes such as coagulation, ﬁbrinolysis and host
defence (Stoop and Craik, 2003).
The structure of ecotin and its mechanism of SP inhibi-
tion have been investigated extensively (McGrath et al.,
1991a; Perona and Craik, 1997; Yang et al., 1998). Ecotin
has also been studied as a macromolecular scaffold to
develop speciﬁc peptidase inhibitors with potential thera-
peutic applications (Stoop and Craik, 2003). Methionine
is present in its reactive site (McGrath et al., 1991b),
although it is not essential for ecotin’s inhibitory activity
against trypsin (Seong et al., 1994). This dichotomy was
resolved when the crystal structure of ecotin revealed that
the protein forms a head to tail dimer that interacts with its
substrate via multiple binding sites, including the active
site of the peptidase (Shin et al., 1996; Yang et al., 1998).
This also explains why a wide range of SPs from the S1A
family are inhibited by ecotin.
Although L. major has 13 SPs belonging to six families,
the parasite apparently lacks genes encoding SPs from
the S1A family of clan PA(S) (Ivens et al., 2005). Three
ecotin orthologous ISP genes are present in the L. major
genome and while it is possible that the encoded ISPs
could regulate the activity of L. major SPs other than family
S1A, or those of other catalytic classes, it is likely that the
ISPs, like ecotin, inhibit host SPs. This could be the trypsin
and chymotrypsin-like peptidases found in the gut of the
sandﬂy vector (Ramalho-Ortigao et al., 2003) or the abun-
dance of S1A SPs that occur in the mammalian host.
Postulated (in vivo) targets of bacterial ecotin include SPs
expressed by cells of the innate immune system (i.e.
neutrophils, mast cells, macrophages), such as NE,
tryptase and cathepsin G, as well as enzymes participat-
ing in the coagulation cascades (Eggers et al., 2004).
Activated neutrophils release SPs together with chromatin
ﬁbres forming extracellular traps that disarm pathogens
and play a role in killing bacteria (Brinkmann et al., 2004).
Ecotin protects E. coli from killing by neutrophils, primarily
due to the inhibition of NE (Eggers et al., 2004).
Macrophages are the principle host cell for Leishmania,
but neutrophils can act as their ﬁrst residence in a mam-
malian host – with the infected neutrophils serving as
vehicles for parasite dissemination (Laufs et al., 2002; Van
Zandbergen et al., 2004; Van Zandbergen et al., 2007).
Equally monocytes, like neutrophils express NE and
cathepsin G (Kargi et al., 1990) and have plasma mem-
brane receptors that enable the uptake of these enzymes
from the surrounding environment (Campbell, 1982).
Leishmania also primes mast cell degranulation following
exposure to chymase and tryptase (de Oliveira et al.,
2005). Thus we hypothesize that the numerous SPs pro-
duced and/or taken up by cells of the immune system in
the course of Leishmania infection are potential targets
for the ISPs. We begin to address the physiological targets
of the Leishmania ISPs by creating L. major mutants
deﬁcient in ISP2 and ISP3 and characterizing their phe-
notype during the early phases of macrophage infection.
Results
ISP genes of L. major
We identiﬁed three ISP genes in the L. major genome
(http://www.genedb.org), ISP1 (LmjF15.0300), ISP2
(LmjF15.0510) and ISP3 (LmjF15.0520). L. major ISP1
is located on the same transcription unit 5′ to ISP2
and ISP3, which are found in tandem (Fig. 1A). An
ISP2 homologue could be identiﬁed in the syntenic
locus for both T. brucei (Tb927.5.1880) and T. cruzi
(Tc00.1047053508533.40), but no ISP3 gene was present
in either of these species. ISP1 is also present in the
syntenic locus in T. brucei (Tb927.5.1730), but the locus
could not be found in the T. cruzi genome – possibly
because the data set is incomplete.
Leishmania major ISP1 and ISP2 encode predicted pro-
teins of 16.5 kDa and 17.5 kDa respectively, which is
similar to the 16.1 kDa for the mature form of E. coli
ecotin. ISP3 is predicted to encode a 41.8 kDa protein,
with an ecotin-like domain at the N-terminal end of the
protein. The C-terminal domain of the protein does not
have sequence identity with known proteins or motifs. An
alignment of ecotin with the three L. major ISPs showed
that they have a shorter N-terminus compared with ecotin
(Fig. 1B). E. coli ecotin is exported to the bacterial peri-
plasm and the ﬁrst 20 amino acids of the protein
sequence act as an export signal peptide. The P1 reactive
site methionine of ecotin occurs in L. major ISP2, but not
ISP1 or ISP3 (Fig. 1B). The percentage identities between
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respectively. Structural analysis of the trypsin–ecotin
complex has revealed two secondary substrate-binding
sites, both of which are surface loops (Yang et al., 1998).
The primary sequence alignment of ecotin and the L.
major ISPs shows that the amino acids of these second-
ary binding sites are highly conserved between the
aligned sequences (Fig. 1B). However, ecotin has a dis-
ulﬁde bond next to its P1 methionine (Shin et al., 1996)
and the three L. major ISPs lack the cysteine residues that
form this bond, although they are conserved in many
bacterial ecotin sequences (Eggers et al., 2004).
Activity and stage-regulated expression of
L. major ISPs
Recombinant ISP1, ISP2 and truncated ISP3 (rISP1,
rISP2, rISP3), each with an N-terminal histidine tag, were
expressed and puriﬁed from E. coli. rISP2 was found to
inhibit the human SPs, NE, trypsin and chymotrypsin,
with Kis of 7.7 (1.4) nM, 83 (2.3) nM and 19 (4.2) nM
respectively. Antibodies raised against rISP1 and rISP2,
and an antipeptide antibody raised for rISP3, allowed the
expression levels of the three L. major ISPs to be exam-
ined by Western blot analyses of three life cycle stages
(Fig. 2). The puriﬁed ISP2 antibodies did not cross-react
with ISP1 but the ISP1 antibodies still recognized ISP2.
However, discrete sized ISP1 and ISP2 proteins could be
resolved on 4–12% gradient SDS-PAGE. Expression of
ISP1 could only be detected in the procyclic and meta-
cyclic promastigotes. ISP2 was expressed in all three
life stages of the parasite with the levels of expression
being greater in metacyclic promastigote and amastigote
stages compared with procyclic promastigotes. ISP3
was not detected in any of the life cycle stages of the
parasite. The antipeptide antibody, however, was able to
detect ISP3 when it was overexpressed in procyclic
promastigotes using an extra-chromosomal construct
(Fig. 2). Elongation factor 1 alpha was used as a loading
control.
1                                               50 
ecotin    (1) MKTILPAVLFAAFATTSAWAAESVQPLEKIAPYPQAEKGMKRQVIQLTPQ
Lmj ISP1    (1) -----------------------MSYCKIEAPYPEAEAGEKRIIFALDPK
Lmj ISP2    (1) -------------MPAGMSDAAGKTLADFKAPYPEPTSQQRRYVIFLDPK
Lmj ISP3    (1) ----------------------MPSLQDYHVPYPAAAPGQVRKVIYLPRQ
51                                             100 
ecotin   (51) EDES---TLKVELLIGQTLEVDCN----LHRLGGKLENKTLEGWGYDYYV
Lmj ISP1   (28) GDEVEQEQCMLQLIPGRVLEMSRNDAANHQTLGGSIEQHTVEGFGAKFFH
Lmj ISP2   (38) GDSKELNDYKVELIPGRVEKVDG---TNVYRMGGNIEERTIDGWGYPYYI
Lmj ISP3   (29) NPTVEQQHLRVQIIPGRHENCDDG---RLYKLTGSVTEETLQGWGYSYYV 
101                                            150 
ecotin   (94) FDKVSSPVSTMMACPDGKK-EKKFVTAYLGDAGMLRYNSKLPIVVYTPDN 
Lmj ISP1   (78) VKLAKQAVSTLMYVHAEDHGEKVRKFVAMSNAPMFPYRSRYPVVVYLPKD
Lmj ISP2   (85) VTLTTMSGTLMMPLG--DAALKRPRFVAMNTKNLYRYNSRLPIVVYMPKD
Lmj ISP3   (76) VTLGDIYAAHRSSSDP----ARATTFVALDESPVIAYNSKLPIVVYVPEG 
151                          182 
ecotin  (143) VDVKYRVWKAEEKIDNAVVR------------ 
Lmj ISP1  (128) AELRYGIWCGGQQMQAATE------------- 
Lmj ISP2  (133) GELRYRIWTVKSTGSGTAKSTKAREM------ 
Lmj ISP3  (122) AELRYRIWTDDASLAQSIQQKPEAPALPQPHL+++ 
A
B
Fig. 1. Leishmania major ISP genes and proteins.
A. A schematic representation of the ISP loci of L. major.
B. Alignment of ecotin with L. major ISPs. The primary P1 reactive site methionine of E. coli ecotin is marked by an asterisk. The two cysteine
residues forming disulﬁde bond in the E. coli ecotin are highlighted above the alignment (:). The E. coli ecotin secondary binding site surface
loops deduced from the trypsin–ecotin complex (Yang et al., 1998) are also highlighted (---). Identical amino acids conserved in at least two of
the aligned sequences are shown in white on a black background. Similar amino acids between the aligned sequences are shown in white
on a grey background. E. coli ecotin (GenBank CAA43954), L. major ISP1 (LmjF15.0300), LmjISP2 (LmjF15.0510) and LmjISP3
(LmjF15.0520). Gene identiﬁers from http://www.genedb.org. Truncated LmjISP3 sequence indicated by +++.
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and ISP3
An ISP2–ISP3 null mutant (Disp2/3) was created by
sequential removal of the ISP locus through homologous
recombination using 5′ ﬂanking region (FR) of the ISP2
and 3′ FR of ISP3 genes with two drug-resistance genes
(Fig. 3A). Southern blotting conﬁrmed the inactivation of
both alleles, as the 2.9 kb wild-type (WT) alleles detected
w i t ha5 ′ ﬂank probe on AgeI-digested genomic DNA(lane
1) were absent in Disp2/3 (lane 2) (Fig. 3B). The absence
of ISP2 in Disp2/3 was conﬁrmed by Western blotting
(Fig. 3C, lane 2). As ISP3 could not be detected by
Western blot analysis of WT promastigote lysates, a
Southern blot using the ISP3 open reading frame (ORF)
as a probe was used to conﬁrm that the gene had been
removed from the Disp2/3 genome (Fig. 3B). The com-
plete ISP2–ISP3 locus was re-introduced into the ribo-
somal locus of Disp2/3 to give Disp2/3 : ISP2–ISP3.
Re-expression of ISP2 in Disp2/3 : ISP2–ISP3 was con-
ﬁrmed by Western blot analysis (Fig. 3C, lane 3), but ISP3
could not be detected using ISP3-speciﬁc antibodies and
Western blotting. We observed that the levels of ISP2
expression in Disp2/3 : ISP2–ISP3 is slightly higher than
in WT parasites, which might result from the re-insertion of
the gene in the ribosomal locus.
ISP2 and ISP3 modulate the infectivity of L. major
to macrophages
Disp2/3 promastigotes grew in vitro at rates similar to
those of WT or Disp2/3 : ISP2–ISP3 promastigotes. The
null mutants also differentiated to metacyclic promasti-
gotes normally, as assessed by the peanut agglutinin
agglutination assay (Sacks and Perkins, 1984) and the
detection of the metacyclic marker HASPB (Fig. 3C).
Analyses of the infectivity of stationary phase promasti-
gotes to macrophages in vitro revealed that Disp2/3
mutants were internalized by elicited macrophages more
efficiently than WT parasites whether infections were per-
formed in the presence (Fig. 4A) or absence (Fig. 4B) of
heat-inactivated fetal bovine serum. Importantly, the
increased internalization of Disp2/3 was reduced to the
WT levels in the presence of the SP inhibitor aprotinin or
of rISP2 (Fig. 4B), indicating that the entry route used by
Disp2/3 is dependent on the activity of trypsin-like SPs.
Neither aprotinin nor rISP2 affected the uptake of WT
parasites (Fig. 4B), suggesting that the SP-dependent
entry route is selectively triggered by ISP-deﬁcient L.
major. The enhanced internalization of ISP-deﬁcient para-
sites was reverted when aprotinin was incubated with
macrophages before the addition of parasites, but not if
this SP inhibitor was added at later times during interac-
tion (Fig. 4C). These observations suggest that SPs are
being triggered at the initial stages of the interaction
between L. major and the host cell. The uptake of Disp2/3
by resident peritoneal macrophages was likewise higher
in comparison with WT (data not shown), indicating that
ISP2 and/or ISP3 modulate parasite internalization in both
resting and activated macrophages.
The entry of L. major into macrophages is mediated in
part by the interaction of the parasite with the comple-
ment 3-receptor (CR3, CD11b/CD18, Mac-1) (Mosser
and Edelson, 1985; Brittingham et al., 1999; Kedzierski
et al., 2004), which acts in conjunction with the mannose-
fucose receptor (MFR) for parasite engulfment, at least
for L. donovani (Blackwell et al., 1985). Thus we sought
to address if CR3 is involved in the uptake of Disp2/3 in
our assay conditions, by blocking the CD11b subunit with
MAB M1/70 (Fig. 4D). We observed a small reduction in
the internalization of WT parasites upon CD11b blocking
(Fig. 4D, white bars). However, blocking of CD11b dra-
matically decreased the uptake of Disp2/3, while pre-
incubation of macrophages with control IgG did not affect
parasite internalization (Fig. 4D, black bars). Uptake of
Disp2/3 : ISP2–ISP3 parasites was unaffected by CD11b
blocking, strongly suggesting that enhanced uptake of
Disp2/3 promastigotes is mediated by increased CR3-
mediated phagocytosis. Mannan puriﬁed from Saccharo-
myces cerevisae was used in order to verify if MFR was
involved in parasite ingestion (Fig. 4E). As previously
observed, blocking of CD11b reduced the uptake of
Disp2/3 but mannan did not affect the uptake of the three
parasite lines, suggesting that MFR does not con-
tribute to the ingestion of L. major promastigotes in this
system.
17
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Fig. 2. Expression of L. major ISPs. Western blot analyses
of L. major cell extracts with anti-ISP antibodies. P, procyclic
promastigotes at 0.5 ¥ 10
7 cells per lane; M, metacyclic
promastigotes at 0.5 ¥ 10
7 cells per lane; A, lesion amastigotes at
10
7 cells per lane; O3, promastigotes expressing ISP3 from an
episome at 0.5 ¥ 10
7 cells per well. Elongation factor 1 alpha
(EF1a) was used as a loading control.
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A. Schematic representation of the ISP2–ISP3 locus in WT L. major (upper) and the constructs for gene deletion. ORFs are shown as grey
arrows and 5′ FR and 3′ FR boxes represent the FR DNA sequences used for gene targeting. The predicted DNA fragment sizes after
restriction digest are shown. HYG, hygromycin-resistance gene; BLE, phleomycin-resistance gene.
B. Southern blot of the WT L. major (lanes 1, 3 and 5) and Disp2/3 (lanes 2, 4 and 6) digested with AgeI or EcoRI/BamHI and probed with
radiolabelled 5′ FR, ISP3 ORF and 3′ FR probes.
C. Western blot of cell extracts from 0.5 ¥ 10
7 puriﬁed metacyclic promastigotes of WT L. major (lane 1), Disp2/3 (lane 2) and
Disp2/3 : ISP2–ISP3 (lane 3) using antibodies against ISP2, HASPB and EF1a.
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activity through the inhibition of SPs
The entry of L. major into macrophages is a largely
passive process for the parasite, which relies on the
phagocytic capacity of host cells (reviewed in Rittig and
Bogdan, 2000). Thus we examined if the overall phago-
cytic activity of macrophages was affected in the pres-
ence of the parasites, using ﬂuorescein-coupled latex
beads (FITC-beads) as a tracer to measure phagocyto-
sis. The phagocytosis of FITC-beads was similar in the
absence (Fig. 5A) or in the presence of WT stationary
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Fig. 4. Enhanced uptake of Disp2/3 by macrophages. Stationary phase promastigotes were incubated with elicited peritoneal macrophages
from BALB/c mice in RPMI supplemented with 10% (v/v) FCS (A) or 0.1% (v/v) BSA (B) at a 3:1 parasite : macrophage ratio for 3 h.
Extracellular parasites were removed with three washes and the adhered cells were ﬁxed and subsequently stained with Giemsa. In (B), the
interaction was performed in the presence of 4 mgm l
-1 of puriﬁed rISP2 or aprotinin (APT). In (C), 10 mgm l
-1 of aprotinin was incubated with
macrophages for 5 min prior to incubation with Disp2/3 0, or 15, 30 or 60 min after addition of parasites and was present for the duration of
the assay. In (D), macrophages were pre-incubated with 10 mgm l
-1 of anti-CD11b M1/70 or with control rat anti-mouse IgG2b for 30 min at
37°C, followed by three washes, before addition of promastigotes. In (E) macrophages were incubated as in (D) or with 1 mg ml
-1 of puriﬁed
Saccharomyces cerevisiae mannan. The number of intracellular parasites was estimated by counting using light microscopy. The experiments
were performed in triplicate, ﬁve independent times in A and B and two independent times in (C to E), the data are means  SD. Key: white
bars, WT parasites; black bars, Disp2/3; grey bars, Disp2/3 : ISP2–ISP3. M; anti-CD11b M1/70. In (A) the asterisk indicates statistical
signiﬁcance at P < 0.05 in relation to WT and P < 0.01 in relation to rISP2, in (B) the asterisk indicates signiﬁcance in relation to all other
samples at P < 0.01. In (D) the signiﬁcant p values between samples are indicated in the graph, in (E) the asterisk indicates signiﬁcance at
P < 0.001 from all other samples without asterisk.
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of WT Leishmania does not alter the basal phagocytic
activity of macrophages. In contrast, the uptake of beads
by macrophages increased signiﬁcantly in the presence
of the Disp2/3 mutants (Fig. 5C) but not in the presence
of the Disp2/3 : ISP2–ISP3 line (Fig. 5D), indicating that
exposure and/or attachment to Disp2/3 selectively
enhances the phagocytic activity of macrophages.
Quantiﬁcation of the average number of intracellular
beads revealed that macrophages internalized twofold
more beads in the presence of the mutants (Fig. 5E),
and that the increase was reversed by addition of apro-
tinin or rISP2. These observations suggest that the dele-
tion of ISP2 and ISP3 rendered Leishmania capable of
upregulating the phagocytic activity of macrophages,
resulting in more efficient uptake of the mutant para-
sites. Furthermore, the mechanism underlying this
enhanced phagocytosis requires the activity of family
S1A SP.
ISP2 and ISP3 are required for the normal
development of L. major in macrophages in vitro
The engulfment of Leishmania by macrophages is fol-
lowed by the Leishmania-containing phagosome deve-
loping into a parasitophorous vacuole, a process that
involves the acquisition of some late endosomal and
lysosomal characteristics (Antoine et al., 1998; Kima,
2007). The persistence of intracellular parasites is
believed to rely on the differentiation of the engulfed pro-
mastigotes to amastigotes, which are resistant to the
acidic environment and hydrolases (Kima, 2007). We
examined the ability of Disp2/3 to establish productive
infections in macrophages in vitro by comparing the
number of intracellular parasites soon after entry (3 h) and
after a 3 day period (Fig. 6). As before, higher numbers of
intracellular Disp2/3 than WT were detected 3 h after
infection (Fig. 6A). Also as expected, the number of intra-
cellular WT amastigotes present at 73 h after infection
Fig. 5. Disp2/3 upregulate the phagocytic
activity of macrophages by a SP-dependent
mechanism. Elicited peritoneal macrophages
from BALB/c mice were incubated with
ﬂuorescein-coupled latex beads in RPMI
supplemented with 0.1% (v/v) BSA, for 30 min
at 37°C, in the absence (A) or in the presence
(B–E) of L. major stationary phase
promastigotes at a 3:1 ratio. Extracellular
beads and parasites were removed by
extensive washing, the adherent cells were
ﬁxed with paraformaldehyde, DAPI-stained
and observed in the ﬂuorescence microscope.
Scale bar: 1 mm. In (E), the number of
intracellular beads/macrophage was estimated
by counting using light microscopy and the
means  SD are presented. As indicated,
aprotinin (APT) or rISP2 were added to the
cultures at 4 mgm l
-1. The experiments were
performed in triplicate, three independent
times. Key: hatched bar, medium; white bars,
WT; black bars, Disp2/3; grey bars,
Disp2/3 : ISP2–ISP3. The asterisk indicates
statistical signiﬁcance from all other samples
at P < 0.05.
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than the number of intracellular promastigotes present 3 h
after infection (9/100 macrophages) (Fig. 6A). In contrast,
the number of intracellular Disp2/3 amastigotes (deﬁned
as amastigotes based on morphology) 73 h after infection
(18/100 macrophages) was similar to that of intracellular
promastigotes found 3 h after infection (22/100 macro-
phages) (Fig. 6B), indicating that the deletion of ISP2 and
ISP3 affected the parasites’ ability to multiply inside
macrophages. The number of intracellular Disp2/3 : ISP2–
ISP3 amastigotes was equivalent to that of WT at 73 h
after infection (46/100), corroborating that the defect in
parasite multiplication inside macrophages overa3d a y
period was caused by the lack of ISP function. We
observed release of Disp2/3 parasites from infected
macrophages after several days (not shown), showing
that the intracellular parasites were viable.
Importantly, addition of rISP2 or aprotinin during the
initial promastigote–macrophage interaction restored the
ability of intracellular Disp2/3 to develop normally in both
elicited (Fig. 6B) and resident macrophages (data not
shown). These observations suggest that the inability of
intracellular Disp2/3 to multiply is a result of the lack
of control of host cell SP activity at the initial stages of
parasite–macrophage interaction. We asked if blocking of
CR3 by M1/70 at the entry stage of Disp2/3 would improve
the subsequent parasite intracellular survival and/or
development in macrophages (Fig. 6C), as seen for the
inhibition of SPs (Fig. 6B). We found reduced numbers of
intracellular Disp2/3 at 3 days post infection as compared
with WT and to Disp2/3:I SP2/ISP3, even when binding to
CR3 was blocked before parasite uptake, suggesting that
signals triggered by CR3 are not responsible for the
downmodulation of parasite growth. To analyse this more
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Fig. 6. The intracellular multiplication of Disp2/3 in macrophages is delayed. Stationary phase promastigotes were incubated with elicited
peritoneal macrophages from BALB/c mice in RPMI supplemented with 0.1% (v/v) BSA, at a 3:1 parasite : macrophage ratio for 3 h.
Extracellular parasites were removed with three washes and the adhered cells were ﬁxed and subsequently stained with Giemsa (A) or
cultured for an additional 70 h in RPMI with 10% (v/v) FCS at 37°C (B and C) before ﬁxation and staining. The number of intracellular
parasites was estimated by counting using light microscopy. In (A and B), the interaction was performed in the presence of 4 mgm l
-1 of
puriﬁed rISP2 or aprotinin (APT), where indicated. The experiments were performed in triplicate, three independent times. In (C),
macrophages were pre-treated with 10 mgm l
-1 of anti-CD11b M1/70 (M) or with rat IgG2b (IgG) for 30 min. at 37°C, followed by three washes,
before addition of promastigotes. The data are means  SD. Key: white bars, WT; black bars, Disp2/3; grey bars, Disp2/3 : ISP2–ISP3. The
asterisk indicates statistical signiﬁcance at P < 0.01 in (A) and (B). In C, the sample with an asterisk indicates statistical signiﬁcance from WT
and from Disp2/3 : ISP2–ISP3 at P < 0.001 (*), and at P < 0.01 (**). In (D), macrophages were incubated with L. major for 3 h, the extracellular
parasites were removed by extensive washing, the cultures were ﬁxed at 24 h, 48 h, 72 h and Giemsa stained. The asterisks indicate
statistical signiﬁcance from WT parasites at P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) at each time point. Key: circle, WT; triangle, Disp2/3;
ﬁlled circle, Disp2/3 : ISP2–ISP3.
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every 24 h after infection. This revealed that the numbers
of intracellular Disp2/3 had signiﬁcantly declined by 24 h
after infection and then multiplied only slightly up to 73 h,
while WT or the re-expressing parasites increased
steadily in numbers over a 3 day period (Fig. 6D). These
data show that the growth of Disp2/3 parasites was
delayed but not totally impaired.
Disp2/3 inhibited the production of nitric oxide by
lipopolysaccharide (LPS)-stimulated macrophages to the
same levels as WT (not shown), removing the possibility
that inability of Disp2/3 to develop in the macrophage was
due to defects in its capacity to induce suppression of
reactive nitrogen species. Likewise, Disp2/3 retained the
capability to block LPS-induced expression of IL-12 by
macrophages (not shown). These observations suggest
that the deﬁcient development of intracellular Disp2/3 is
not linked to alterations in the ability to suppress macro-
phage activation. Moreover, Disp2/3 amastigotes isolated
from mice lesions were able to infect macrophages in vitro
and multiply at the same level as WT (data not shown),
suggesting that the defect in intracellular development of
Disp2/3 is entirely restricted to the initial stages of infec-
tion with promastigotes.
Infection of mice with ISP mutants
The consequences of the deﬁciency in ISP2 and ISP3t o
Leishmania infection in the host were evaluated by the
inoculation of puriﬁed metacyclic promastigotes into the
footpads of susceptible mice, followed by the determina-
tion of parasite burden for 1–5 days post infection (Fig. 7).
Following 24 h of infection, the parasite burden in animals
infected with the mutant line was about fourfold higher
than those of mice infected with WT or the re-expressing
parasites (Fig. 7A). The higher burden of Disp2/3 para-
sites in mice was sustained until day 3 after infection
(Fig. 7B), but became approximately equivalent to that of
WT by day 5 (Fig. 7C). We also monitored the progression
of lesions in infected mice over a 21 day period and
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Fig. 7. Increased growth of Disp2/3 in mice at the early stages of infection. Puriﬁed metacyclic promastigotes (5 ¥ 10
5) were injected in the
footpad of BALB/c mice (three mice per group) and the parasite burden was determined by limiting dilution in vitro at 24 h (A), 3 days
(B) and 5 days (C) post infection. Key: white bars, WT; black bars, Disp2/3; grey bars, Disp2/3 : ISP2–ISP3. The data are means  SD
and were performed three independent times. In (A), the asterisk indicates statistical signiﬁcance from WT at P < 0.01. In (D) BALB/c mice
(ﬁve per group) were infected with metacyclic promastigotes (5 ¥ 10
5) in the left footpad and were injected with an equivalent volume
of PBS in the right footpad. Key: square, WT; triangle, Disp2/3; circle, Disp2/3 : ISP2/ISP3. The experiments were performed four independent
times.
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cyclic promastigotes of Disp2/3, the re-expressing line or
WT developed similarly (Fig. 7D).
Discussion
In the present study we have characterized L. major ISP
genes that encode proteins with sequence similarity to the
bacterial SP inhibitor ecotin. The distribution of ecotin is
unusual in that it has been found in a very limited number
of bacteria; just 15 genera including Escherichia,
Pseudomonas, Salmonella and Yersinia, from the 335
fully sequenced bacterial genomes available in the
Comprehensive Microbial Resource (http://cmr.jcvi.org/
cgi-bin/CMR/shared/Genomes.cgi) and in trypanosoma-
tids (Leishmania and Trypanosoma). The ISP genes may
therefore have arisen in trypanosomatids due to a hori-
zontal gene transfer event from a bacterium into an organ-
ism that preceded the divergence of Trypanosoma and
Leishmania (Opperdoes and Michels, 2007). There is also
divergence in the trypanosomatid ISP gene family as
ISP3 is only found in Leishmania and not Trypanosoma.
Its proximity to ISP2 and the unusual C terminal extension
encoded indicates that ISP3 may have arisen through an
ISP2 gene duplication event, after the divergence of
Leishmania and Trypanosoma.
Ecotin is a potent inhibitor of S1A family (trypsin-fold)
SPs, yet E. coli lacks these enzymes. This also appears to
be the case for Leishmania, as the parasite lacks S1A
family SPs but contains ISP2, which we have demon-
strated to be a potent inhibitor of different mammalian S1A
familySPsincludingtrypsinandNE.IntheabsenceofS1A
family SPs in Leishmania, the ISPs could potentially target
host trypsin-type SPs. The possible role of Leishmania
ISPsinprotectingtheparasitefromthedigestiveSPsinthe
sandﬂy gut is currently under investigation, while in this
study we investigated the role of ISPs in the early stages of
infectioninthemammalianhost.Unlikeecotin,Leishmania
ISPs lack an N-terminal signal sequence, suggesting that
they are not targeted into the secretory pathway, although
theymaybesecretedviaanon-classicalsecretorymecha-
nism or released by apoptotic promastigotes (Van
Zandbergen et al., 2006; 2007). Thus, our hypothesis
incorporates the idea of inhibitor release by the parasite
causing an effect on mammalian SPs.
ISP1 expression could be detected in both procyclic
promastigotes and metacyclic promastigotes, but not
amastigotes – consistent with the protein having a role in
the sandﬂy vector or early in infection of the mammalian
host. In contrast, ISP2 is expressed in all life cycle stages,
but with a higher level of expression in metacyclic pro-
mastigotes and amastigotes, suggestive of a role in initia-
tion and persistence of infection of the mammalian host.
Here we have investigated the roles of ISP2 and ISP3b y
generating ISP2/ISP3-deﬁcient L. major. As expression of
ISP3 was not detected in either metacyclic promastigotes
or amastigotes, it is likely that the phenotypes observed in
this study for Disp2/isp3 are primarily due to ISP2.
The phenotypic analyses of the Disp2/isp3 mutants
showed that the lack of these genes enhanced parasite
infectivity in vitro, as a result of increased parasite uptake
by peritoneal macrophages. We also showed that expo-
sure of macrophages to Disp2/3 increased the phago-
cytosis of inert particles, suggesting that upregulation
of macrophage phagocytic activity is responsible for
increased infectivity of Disp2/3 in vitro. Increased uptake
of Disp2/3 was observed in the presence or absence of
serum, indicating that a common mechanism susceptible
to regulation by ISPs is involved. CR3 was found to be the
predominant receptor used by Disp2/3, but not by WT or
the re-expressing parasites. Although the ﬁxation of
complement components at the surface of Leishmania
mainly requires the presence of serum as a source of C3
(Mosser and Edelson, 1987), the C3 endogenously pro-
duced by macrophages might represent an alternative
source of complement in its absence. Additionally, LPG
and gp63 have binding sites for CD11b (Russell
and Wright, 1988; Talamas-Rohana et al., 1990). We
observed that Disp2/3 adhere to macrophages more than
WT at low temperature, in the absence of serum (M.S.
Faria and A.P.C.A. Lima, unpubl. obs.), suggesting that
more efficient adhesion contributes to increased infectiv-
ity. Although CR3-mediated phagocytosis, without FMR
association, seems to be the main mechanism driving the
internalization of ISP-deﬁcient Leishmania, we cannot dis-
count the possibility that additional receptors are involved
in the uptake of the mutant lines.
Intriguingly, our results show that the receptor(s)
involved in the differential engulfment of Disp2/isp3 are
associated, either directly or indirectly, with the activity of
SPs as internalization of the parasites were brought to WT
levels in the presence of aprotinin or rISP2. We have not
addressed which SPs are mediating increased activation
of phagocytosis, but NE is one candidate. It has been
reported that in polymorphonuclear leukocyte NE is an
endogenous ligand for CR3, and that its binding, via an
active site interaction, to CR3 modulates leucocyte adhe-
sion via competition with other endogenous ligands (Cai
and Wright, 1996). NE is also expressed by macrophages,
although its association with CR3 has not been shown in
this cell type. Furthermore, the activity of NE triggers
toll-like receptor 4-mediated responses (Devaney et al.,
2003), suggesting that the activity of SPs might be tightly
associated with the modulation of leucocyte receptors.
Another S1A family SP, factor X, has also been shown to
associate with CR3, in an interaction involving peptidase
activation (Altieri et al., 1988) and so this could also be a
target of ISPs.
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promastigotes leads to the inactivation of infected cells,
contributing to the subsequent intracellular survival of
the parasite and allowing ampliﬁcation as intracellular
amastigotes at sites of infection (Mosser and Edelson,
1987). We observed that intracellular Disp2/3 were par-
tially eliminated within 24 h of infection, and slowly recov-
ered growth after 48 h. Importantly, Disp2/3 grew normally
inside macrophages when SP inhibitors were added to the
initial stages of the promastigote–macrophage inter-
action, suggesting that the activity of SPs triggered during
parasite contact is responsible for the subsequent defect
in the intracellular development of engulfed parasites. The
production of nitric oxide (NO) has been implicated in the
control of the growth of L. major in mice (Wei et al., 1995),
but we observed no difference in the capacity of Disp2/3
parasites to inhibit LPS-induced NO production by
macrophages as compared with WT (data not shown),
suggesting that this reactive nitrogen species is not
mediating selective killing of Disp2/3. However, we cannot
exclude that SPs engaged by Disp2/3 during interaction
with macrophages trigger the production of reactive
oxygen species, which could be responsible for the
control of parasite growth. These observations strongly
suggest that although ISP deletion enhances parasite
entry to macrophages, this is not in fact beneﬁcial as ISP
function at the initial stages of parasite–macrophage inter-
action is required to prevent premature death and enable
normal intracellular growth.
The defect in intracellular development of Disp2/3 in
vitro was different from the result observed in vivo, where
mice infected with Disp2/3 had a higher parasite burden at
the early stages of infection (up to three days) in compari-
son with those infected with WT or with the re-expressing
lines. It has been reported that the phagocytosis of apo-
ptotic neutrophils by macrophages infected with L. major
enhances the intracellular multiplication of parasites in
cells derived from BALB/c mice due to the induction of
TGF-b (Ribeiro-Gomes et al., 2004). The depletion of
polymorphonuclear leukocyte prior to infection resulted in
lower parasite burden 13 days later, indicating that neu-
trophils are required for the optimal development of L.
major in vivo. More recently, studies in vivo using intravital
microscopy suggest that neutrophils recruited to the site
of infection rapidly engulf L. major and are the primary
host cells for the parasites within the ﬁrst 48 h (Peters
et al., 2008). In vivo, it is possible that, similar to what was
observed in macrophage infections in vitro, Disp2/3 could
be internalized by neutrophils at higher numbers in com-
parison with WT parasites and survive in these cells,
leading to higher parasite burden in the ﬁrst 24 h. Alter-
natively, we could hypothesize that the signals triggered
by Disp2/3 during the parasite–macrophage contact,
which resulted in the downregulation of intracellular para-
site replication observed in vitro, are overcome in vivo by
the deactivating stimulus given by neutrophils. In the
absence of such downregulation, Disp2/3 that were inter-
nalized at higher numbers by macrophages can develop
normally, leading to enhanced parasite burden, which is
controlled later on. Disp2/3 was capable of generating
lesions in the footpad of mice, although the lesions were
slightly smaller in size in the ﬁrst 11 days. The production
of IFN-g, IL-4, IL-10 and TNF-a in lymph nodes of mice 15
days after parasite inoculation was similar between infec-
tions with the different lines, suggesting that there was no
major alteration in the development of the adaptive
immune response. ISP1 is also expressed in metacyclic
promastigotes and might compensate in part for the loss
of ISP2 in the early infection process, a hypothesis that
can be tested with ISP1/ISP2/ISP3 triple mutants that we
have recently generated. ISP1 expression could not be
detected in amastigotes, so is unlikely to compensate for
ISP2 after establishment of infection. Thus ISPs would not
appear to be required for dissemination or persistence in
the mammalian host.
At the initial stages of Leishmania infection in vivo,
neutrophils are the ﬁrst cells recruited to the site of infec-
tion (Lima et al., 1998; Peters et al., 2008) and they have
been shown to exert an important modulatory role on the
outcome of the immune response in susceptible mice
(Chen et al., 2005). In response to microbial components,
neutrophils secrete the contents of azurophilic granules
containing a high density of SPs, such as NE, cathepsin G
and PR3, and extracellular NETs, which present trapped
active NE to the surrounding milieu (Brinkmann et al.,
2004). Therefore, it is likely that Leishmania are exposed
to large amounts of SPs at the site of infection, which
could be modulated by the ISPs.
Taken together, the results in this study suggest that the
inhibition of host SPs by ISP2 at the initial stages of
the parasite–macrophage interaction is required for the
optimal initial intracellular adaptation of L. major for living
in macrophages, which is crucial for the establishment of
productive infections in the host. Investigations into the
role of ISP in the interaction of Leishmania and neutro-
phils are ongoing and should reveal more on the role of
ISPs in the infection process.
Experimental procedures
Parasites
Leishmania major Friedlin (MHOM/JL/80/Friedlin) were grown as
promastigotes in modiﬁed Eagle’s medium (designated HOMEM
medium) supplemented with 10% heat-inactivated fetal calf
serum (FCS) at 25°C as described previously (Besteiro et al.,
2006). The following antibiotics were used at the indicated con-
centration for the selection of transfectants: 50 mgm l -1 Hygro-
mycin B (Roche), 25 mgm l
-1 G418 (Invitrogen), 10 mgm l
-1
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-1 Puromycin dihydrochlo-
ride (Calbiochem). L. major metacyclic promastigotes were
isolated from stationary phase culture (2.5 ¥ 10
7 cells ml-1)
by agglutination of promastigote cells with peanut lectin as
described previously (Sacks et al., 1985). Metacyclic promasti-
gotes represented 17.8%, 18.2% and 20.1% in L. major WT,
Disp2/3 and Disp2/3:I SP2/ISP3 respectively. Lesion amasti-
gotes were puriﬁed as previously described (Hart et al., 1981).
Generation of L. major ISP null mutants, re-expressors
and overexpressors
The two plasmids containing the antibiotic-resistance cassettes
used for the double-allele inactivation of ISP2/ISP3 were pro-
duced as follows: the 418 bp 5′ FR was generated by PCR with
primers OL1403 and OL1404 (Table 1). The 600 bp 3′ FR was
generated by PCR with primers OL1405 and OL1406. The PCR
fragments were subcloned into pGEM-T and then released by
restriction digest with HindIII/SalI for the 5′ FR, and XmaI/BglII for
the 3′ FR. The fragments were sequentially cloned into similarly
digested hygromycin-resistant plasmid pGL792 (Besteiro et al.,
2004) to give pGL959. To produce a phleomycin-resistant knock-
out construct the hygromycin cassette from pGL959 was
replaced with the SpeI/BamHI phleomycin-resistance cassette to
give pGL961. The integration cassette from plasmids pGL959
and pGL961 were excised by digestion with BglII and HindIII
before transfection. For the re-expression construct, a 2.8 kb
PCR fragment containing ISP2 ORF, ISP3 ORF and the inter-
genic genomic DNA region was ampliﬁed from L. major DNA with
the primers OL1657 and OL1473 containing BglII and NotI
restriction sites. The PCR fragment was subcloned in PCRscript
(Stratagene). The 2.8 kb ISP2–ISP3 insert was cloned into the
pRIB expression vector (Garami and Ilg, 2001) using BglII and
NotI to give pGL1005. The integration cassette from pGL1005
was excised by digestion with PacI and PmeI before transfection.
L. major promastigotes were electroporated with 20 mgo ft h e
linearized integration cassettes and transfectants were selected
with the appropriate antibiotics as previously described (Besteiro
et al., 2006). Full-length ISP3 was ampliﬁed by PCR using
primers OL1459 and OL1320. The PCR product was subcloned
into pPCRscript (Stratagene). The insert was released from
pPCRscript by XmaI/BamHI digest and ligated into similarly
digested pXG vector generating the ISP3 overexpression con-
struct pGL1004.
Southern blot analysis
Genomic DNA (gDNA) was isolated from the WT and mutant
cell lines with the DNeasy kit (Qiagen). Three micrograms of
gDNA was digested with appropriate restriction enzymes,
electrophoresed through a 0.8% agarose gel and blotted onto
Hybond C Super (Amersham Pharmacia). The DNA probes
were radiolabelled with a random priming kit (Stratagene) and
the blots were hybridized at 65°C overnight. The membranes
were washed twice with 2¥ SSC with 0.1% SDS for 15 min at
65°C and rinsed once with 0.2¥ SSC at 65°C. Phosphostorage
screens were exposed overnight and the membranes visualized
using a Typhoon 8610 variable mode imager (Molecular
Dynamics).
Protein expression, Western blotting and antibodies
Leishmania major ISP1 and ISP2 were ampliﬁed by PCR from
gDNA using OL1315-OL1316 and OL1660-OL1318 respec-
tively. The PCR products were subcloned into pPCRscript
(Stratagene). The inserts were released from pPCRscript by
NdeI/BamHI digest and ligated into similarly digested pET-15b
(Novagen). The constructs pGL998 (ISP1/pET15b) and
pGL1179 (ISP2/pET15b) were used to express N-terminal his-
tagged ISP1 and ISP2 respectively. The proteins were isolated
using nickel agarose affinity puriﬁcation, ion-exchange chroma-
tography. LPS was removed using Detoxi-Gel (Pierce) accord-
ing to manufacturer’s instructions. Puriﬁed recombinant ISP1
and ISP2 were used to raise antisera in sheep. The antibodies
were puriﬁed from the serum using immobilized recombinant
protein or peptide onto AminoLink Plus coupling gel (Pierce).
To remove possible cross-reaction between ISP1 and ISP2
antibodies, anti-ISP1 antisera was exposed to immobilized
recombinant ISP2, and vice versa, prior to puriﬁcation. ISP3
antibodies were produced in rabbit against a peptide corre-
sponding to the last 20 amino acids of the encoded protein
(ASASSTKSGNGSKADPVDGK). The antibodies were puriﬁed
from the antiserum using immobilized peptide onto AminoLink
Plus coupling gel (Pierce).
The following L. major cell lysates were used for the Western
blots: log phase promastigote 0.5 ¥ 10
7 cells per well, puriﬁed
metacyclics lysates 0.5 ¥ 10
7 cells per well and puriﬁed lesion
amastigote lysates 10
7 cells per well. For the ISP3 Western blot,
a log phase promastigote lysate overexpressing ISP3 was used
Table 1. Primers used in the study.
Primer Restriction site Sequence (restriction sites are underlined)
OL1403 HindIII CGAAGCTTGGATCGACTCAATCACGCCAACG
OL1404 SalI CAGTCGACTGAGTTAGAGTGGAGTGTTG
OL1405 XmaI TACCCGGGAAGGAGCTGCACCACATGGGCA
OL1406 BglII GCAGATCTTTGTTCATCGGAGAAGGGATGC
OL1657 BglII GCAGATCTATGCCCGCAGGGATGTCCGAC
OL1473 NotI ATGCGGCCGCCTACTTCCCGTCTACGGGGTC
OL1315 NdeI CGCATATGTCATACTGCAAGATCGAGGCC
OL1316 BamHI GCGGATCCTCACTCCGTGGCTGCCTGCATC
OL1660 NdeI ATCATATGCCCGCAGGGATGTCCGAC
OL1318 BamHI GCGGATCCTCACATCTCCCTTGCCTTGGTG
OL1320 BamHI GCGGATCCCTACTTCCCGTCTACGGGGTC
OL1459 XmaI TACCCGGGATGCCCTCCCTCCAGGACTAC
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7 cells per well). The cell lysates were separated by
4–12% gradient SDS-PAGE and the proteins were transferred
onto a PVDF membrane. Affinity-puriﬁed anti-ISP1 and anti-ISP2
sheep antibodies and affinity-puriﬁed anti-ISP3 rabbit antibodies
were used in Western blots to detect each individual ISP. The
antibodies were used at 1/1000 dilution. A secondary anti-sheep
or anti-rabbit IgG antibodies coupled to horseradish peroxidase
(Santa Cruz Biotechnology) were used ata1i n4000 dilution.
Rabbit polyclonal antiserum speciﬁc for HASPB (a gift from Prof.
D. Smith, York University) was used at 1/1000 dilution. Following
each Western blot, the membranes were stripped and re-probed
with anti-elongation factor 1 alpha monoclonal antibody (Upstate
Cell Signalling Solutions) as a loading control. This antibody was
used at 1 in 5000 dilution and secondary anti-mouse IgG anti-
body coupled to horseradish peroxidase (Promega) was used at
1 in 4000 dilution. The Western blots were revealed by soaking
the membrane in SuperSignal West Pico chemiluminescent sub-
strate (Pierce) exposing the membranes to X-ray ﬁlms.
Ki determination
The human SPs trypsin (0.21 mM), chymotrypsin (5 nM) and NE
(3 mM) were incubated in 100 mM Tris (pH 8) with varying con-
centrations of ISP2 (100 pM to 30 mM) for 20 min prior to the
addition of the appropriate substrate, Bz-R-AMC, Suc-AAPF-
AMC and MeOSuc-AAPV-AMC respectively (Calbiochem).
Substrates were used at a saturating concentration, which
was determined experimentally (data not shown). Activity was
determined by the change in ﬂuorescence (lex = 355 nm,
lem = 460 nm) at 21°C using an EnVision 2102 plate reader
(Perkin Elmer, Bucks). The effect on the initial velocity was cal-
culated and curves were ﬁt using FigP (FigPsoft Corporation,
Canada). Relative activity was calculated from the ratio of initial
velocity in the presence of inhibitor to that of uninhibited controls.
Experiments were carried out in triplicate and results are
expressed as the mean  SEM. Ki values were calculated using
the equation for tight binding inhibitors in equilibrium
(Ki = (Ki ¥ [S])/([S] + Km).
Macrophage infection assays
Peritoneal macrophages from BALB/c mice were elicited by injec-
tion of 1 ml of 1% thioglycolate in the peritoneal cavity and
collected 3 days later upon injection of 5 ml of ice-cold RPMI
1640-medium (Sigma-Aldrich, Egham, UK) in the peritoneal
cavity, followed by gentle massage. The cells were washed,
plated onto glass coverslips in a 24-well tissue culture plate at a
density of 3 ¥ 10
5 ml-1 and cultivated overnight in RPMI supple-
mented with 10% of FCS (Cultilab, Campinas, SP, Brazil). The
cells were washed three times with Hank’s balanced salt saline
(HBSS) and incubated with stationary phase promastigotes in
RPMI, supplemented with 0.1% bovine serum albumin (BSA)
(Sigma-Aldrich, St Louis, MO, USA), at 37°C for 3 h. The cover-
slips were washed for the removal of extracellular parasites, ﬁxed
with Bouin overnight and stained with Giemsa (Laborclin,
Pinhais, PR, Brazil). The number of intracellular parasites was
determined by counting at least 100 cells per replicate under the
light microscope. Where indicated in the ﬁgure legends, the infec-
tions were performed in the presence of 10% FCS. Aprotinin
(Sigma-Aldrich, St., MO, USA) or rISP2 (4 mgm l
-1 each) were
added to macrophages 5 min prior to addition of the parasites
and remained during the 3 h of interaction. Anti-mouse CD11b
monoclonal antibodies (M1/70) or rat IgG2 (BD Bioscience
Pharmingen, San Jose, CA, USA) were incubated at 10 mgm l -1
with macrophages in RMPI-FCS for 1 h, and removed by exten-
sive washing before the addition of promastigotes in RPMI-BSA.
For the survival assays, the macrophages were infected as
described above for 3 h and after the removal of extracellular
parasites the cells were cultured at 37°C, in RPMI supplemented
with 10% FCS for 24, 48 or 72 h.
Phagocytosis of latex beads by macrophages
Elicited peritoneal macrophages were plated onto glass cover-
slips and cultivated overnight in RPMI-10% FCS. The cells were
washed with HBSS and adherent cells were incubated with
Fluorescein-coupled latex beads of 500 nm diameter (Molecular
Probes, USA) diluted 1:2000, in RPMI-0.1% BSA, for 30 min at
37°C. Extracellular beads were removed by washing six times
with HBSS and the cells were ﬁxed in paraformaldehyde 4%,
washed with phosphate-buffered saline pH 7.2, incubated with
DAPI and mounted on N-propylgalacto glass slides. The slides
were observed in an Axioplan ﬂuorescence microscope for
estimation of the average number of beads per macrophage.
Where indicated, L. major stationary phase promastigotes were
co-incubated with the latex beads and the macrophages at a 3:1
parasite–host cell ratio.
In vivo assay of L. major infectivity
Stationary phase promastigotes were centrifuged at 2000 g,
re-suspended in 0.5 ml of HOMEM and incubated with 50 mgm l
-1
peanut lectin for 20 min at room temperature for the agglutination
of procyclic promastigotes. The cells were centrifuged at 100 g
for 5 min, the supernatant containing metacyclic promastigotes
was recovered and the cells were washed with HBSS. BALB/c
mice (4–6 weeks) were infected in the footpads with 2 ¥ 10
5
metacyclic promastigotes and the parasite burden in paws and in
the draining lymph nodes were evaluated between 1 and 10
days. The mice were sacriﬁced, the bottom tissue of the footpad
was removed and ruptured to homogeneity with the back of a
syringe through a nylon membrane in 2 ml of Schneider’s
medium supplemented with 10% FCS, 2% urine. The popliteal
lymph nodes were collected and submitted to rupture as
described above. One hundred microlitres of the cell homoge-
nates was submitted to serial dilutions in 24-well plates and
cultivated at 27°C for 5–7 days. The number of parasites in the
highest dilution was estimated by counting in a Neubauer
chamber. The parasite concentrations in the footpad or lymph
nodes were subsequently calculated as: number of parasites/ml/
well ¥ dilution factor in 24-well plate ¥ dilution factor of the initial
homogenate.
Statistical analyses
The analysis of signiﬁcance of the data was performed by analy-
sis of variance, using the GraphPad Prism 4.0 Program. The data
were analysed by one-way ANOVA using the Bonferroni post-test,
at a signiﬁcance level of 5%. In Fig. 6D the data were analysed
by two-way ANOVA using the Bonferroni post-test, at a signiﬁ-
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indicated in the ﬁgures with asterisks and the P-values are indi-
cated in the legends.
Acknowledgements
This work was funded by the Medical Research Council (Grant
Numbers G9722968, G0000508, G0700127), The Wellcome
Trust (Grant Numbers 072349, 081877), CNPq and FAPERJ.
A.P.C.A.L. and G.A.D.R. are Research Fellows from CNPq. We
thank Alan Scott for help with puriﬁcation of recombinant pro-
teins, Edna Lopes for technical assistance in parasite culture and
the Laboratório Hertha Mayer de Ultra Estrutura e Biologia
Celular for help with the ﬂuorescence microscopy.
References
Altieri, D.C., Morrissey, J.H., and Edgington, T.S. (1988)
Adhesive receptor Mac-1 coordinates the activation of
factor X on stimulated cells of monocytic and myeloid dif-
ferentiation: an alternative initiation of the coagulation pro-
tease cascade. Proc Natl Acad Sci USA 85: 7462–7466.
Antoine, J.C., Prina, E., Lang, T., and Courret, N. (1998) The
biogenesis and properties of the parasitophorous vacuoles
that harbour Leishmania in murine macrophages. Trends
Microbiol 6: 392–401.
Besteiro, S., Coombs, G.H., and Mottram, J.C. (2004) A
potential role for ICP, a leishmanial inhibitor of cysteine
peptidases, in the interaction between host and parasite.
Mol Microbiol 54: 1224–1236.
Besteiro, S., Williams, R.A.M., Morrison, L.S., Coombs, G.H.,
and Mottram, J.C. (2006) Endosome sorting and auto-
phagy are essential for differentiation and virulence of
Leishmania major. J Biol Chem 281: 11384–11396.
Blackwell, J.M., Ezekowitz, R.A., Roberts, M.B., Channon,
J.Y., Sim, R.B., and Gordon, S. (1985) Macrophage
complement and lectin-like receptors bind Leishmania in
the absence of serum. J Exp Med 162: 324–331.
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhle-
mann, Y., Weiss, D.S., et al. (2004) Neutrophil extracellular
traps kill bacteria. Science 303: 1532–1535.
Brittingham, A., Chen, G., McGwire, B.S., Chang, K.P., and
Mosser, D.M. (1999) Interaction of Leishmania gp63 with
cellular receptors for ﬁbronectin. Infect Immun 67: 4477–
4484.
Cai, T.Q., and Wright, S.D. (1996) Human leukocyte elastase
is an endogenous ligand for the integrin CR3 (CD11b/
CD18, Mac-1, alpha M beta 2) and modulates polymorpho-
nuclear leukocyte adhesion. J Exp Med 184: 1213–1223.
Campbell, E.J. (1982) Human leukocyte elastase, cathepsin
G, and lactoferrin: family of neutrophil granule glycopro-
teins that bind to an alveolar macrophage receptor. Proc
Natl Acad Sci USA 79: 6941–6945.
Chen, L., Zhang, Z.H., Watanabe, T., Yamashita, T., Kobay-
akawa, T., Kaneko, A., et al. (2005) The involvement of
neutrophils in the resistance to Leishmania major infection
in susceptible but not in resistant mice. Parasitol Int 54:
109–118.
Chung, C.H., Ives, H.E., Almeda, S., and Goldberg, A.L.
(1983) Puriﬁcation from Escherichia coli of a periplasmic
protein that is a potent inhibitor of pancreatic proteases.
J Biol Chem 258: 11032–11038.
Devaney, J.M., Greene, C.M., Taggart, C.C., Carroll, T.P.,
O’Neill, S.J., and McElvaney, N.G. (2003) Neutrophil
elastase up-regulates interleukin-8 via toll-like receptor 4.
FEBS Lett 544: 129–132.
Eggers, C.T., Murray, I.A., Delmar, V.A., Day, A.G., and
Craik, C.S. (2004) The periplasmic serine protease inhibi-
tor ecotin protects bacteria against neutrophil elastase.
Biochem J 379: 107–118.
Garami, A., and Ilg, T. (2001) The role of phosphomannose
isomerase in Leishmania mexicana glycoconjugate syn-
thesis and virulence. J Biol Chem 276: 6566–6575.
Hart, D.T., Vickerman, K., and Coombs, G.H. (1981) A quick,
simple method for purifying Leishmania mexicana amasti-
gotes in large numbers. Parasitology 82: 345.
Ivens, A.C., Peacock, C.S., Worthey, E.A., Murphy, L.,
Aggarwal, G., Berriman, M., et al. (2005) The genome of
the kinetoplastid parasite, Leishmania major. Science 309:
436–442.
Kargi, H.A., Campbell, E.J., and Kuhn, C., III (1990) Elastase
and cathepsin G of human monocytes: heterogeneity and
subcellular localization to peroxidase-positive granules.
J Histochem Cytochem 38: 1179–1186.
Kedzierski, L., Montgomery, J., Bullen, D., Curtis, J., Gar-
diner, E., Jimenez-Ruiz, A., et al. (2004) A leucine-rich
repeat motif of leishmania parasite surface antigen 2 binds
to macrophages through the complement receptor 3.
J Immunol 172: 4902–4906.
Kima, P.E. (2007) The amastigote forms of Leishmania are
experts at exploiting host cell processes to establish infec-
tion and persist. Int J Parasitol 37: 1087–1096.
Laufs, H., Müller, K., Fleischer, J., Reiling, N., Jahnke, N.,
Jensenius, J.C., et al. (2002) Intracellular survival of Leish-
mania major in neutrophil granulocytes after uptake in the
absence of heat-labile serum factors. Infect Immun 70:
826–835.
Lima, G.M., Vallochi, A.L., Silva, U.R., Bevilacqua, E.M.,
Kiffer, M.M., and Abrahamsohn, I.A. (1998) The role of
polymorphonuclear leukocytes in the resistance to cutane-
ous Leishmaniasis. Immunol Lett 64: 145–151.
McGrath, M.E., Hines, W.M., Sakanari, J.A., Fletterick, R.J.,
and Craik, C.S. (1991a) The sequence and reactive site of
ecotin. A general inhibitor of pancreatic serine proteases
from Escherichia coli. J Biol Chem 266: 6620–6625.
McGrath, M.E., Hines, W.M., Sakanari, J.A., Fletterick, R.J.,
and Craik, C.S. (1991b) The sequence and reactive site of
ecotin. A general inhibitor of pancreatic serine proteases
from Escherichia coli. J Biol Chem 266: 6620–6625.
McGrath, M.E., Gillmor, S.A., and Fletterick, R.J. (1995)
Ecotin: lessons on survival in a protease-ﬁlled world.
Protein Sci 4: 141–148.
Monteiro, A.C.S., Abrahamson, M., Lima, A.P.C.A., Vannier-
Santos, M.A., and Scharfstein, J. (2001) Identiﬁcation,
characterization and localization of chagasin, a tight-
binding cysteine protease inhibitor in Trypanosoma cruzi.
J Cell Sci 114: 3933–3942.
Mosser, D.M., and Edelson, P.J. (1985) The mouse macro-
phage receptor for C3bi (CR3) is a major mechanism in the
phagocytosis of Leishmania promastigotes. J Immunol
135: 2785–2789.
Serine peptidase inhibitors of Leishmania 119
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Cellular Microbiology, 11, 106–120Mosser, D.M., and Edelson, P.J. (1987) The third component
of complement (C3) is responsible for the intracellular sur-
vival of Leishmania major. Nature 327: 329–331.
Mottram, J.C., Coombs, G.H., and Alexander, J. (2004) Cys-
teine peptidases as virulence factors of Leishmania. Curr
Opin Microbiol 7: 375–381.
de Oliveira, M.P., Lima, M.C., Calheiros, A.S., Martins, M.A.,
Antas, P.R., De Luca, P.M., et al. (2005) Leishmania
(Viannia) braziliensis: human mast cell line activation
induced by logarithmic and stationary promastigote
derived-lysates. Exp Parasitol 109: 72–79.
Opperdoes, F.R., and Michels, P.A. (2007) Horizontal gene
transfer in trypanosomatids. Trends Parasitol 23: 470–
476.
Perona, J.J., and Craik, C.S. (1997) Evolutionary divergence
of substrate speciﬁcity within the chymotrypsin-like serine
protease fold. J Biol Chem 272: 29987–29990.
Peters, N.C., Egen, J.G., Secundino, N., Debrabant, A.,
Kimblin, N., Kamhawi, S., et al. (2008) In vivo imaging
reveals an essential role for neutrophils in leishmaniasis
transmitted by sand ﬂies. Science 321: 970–974.
Ramalho-Ortigao, J.M., Kamhawi, S., Rowton, E.D., Ribeiro,
J.M.C., and Valenzuela, J.G. (2003) Cloning and charac-
terization of trypsin- and chymotrypsin-like proteases from
the midgut of the sand ﬂy vector Phlebotomus papatasi.
Insect Biochem Mol Biol 33: 163–171.
Rawlings, N.D., Tolle, D.P., and Barrett, A.J. (2004) Evolu-
tionary families of peptidase inhibitors. Biochem J 378:
705–716.
Ribeiro-Gomes, F.L., Otero, A.C., Gomes, N.A., Moniz-de-
Souza, M.C., Cysne-Finkelstein, L., Arnholdt, A.C., et al.
(2004) Macrophage interactions with neutrophils regulate
Leishmania major infection. J Immunol 172: 4454–4462.
Rigden, D.J., Mosolov, V.V., and Galperin, M.Y. (2002)
Sequence conservation in the chagasin family suggests a
common trend in cysteine proteinase binding by unrelated
protein inhibitors. Protein Sci 11: 1971–1977.
Rittig, M.G., and Bogdan, C. (2000) Leishmania–host–cell
interaction: complexities and alternative views. Parasitol
Today 16: 292–297.
Russell, D.G., and Wright, S.D. (1988) Complement receptor
type 3 (CR3) binds to an Arg-Gly-Asp-containing region of
the major surface glycoprotein, gp63, of Leishmania pro-
mastigotes. J Exp Med 168: 279–292.
Sacks, D.L., and Perkins, P.V. (1984) Identiﬁcation of an
infective stage of Leishmania promastigotes. Science 223:
1417–1419.
Sacks, D.L., Hieny, S., and Sher, A. (1985) Identiﬁcation of
cell surface carbohydrate and antigen changes between
non-infective and infective developmental stages of Leish-
mania major promastigotes. J Immunol 135: 564–569.
Sajid, M., and McKerrow, J.H. (2002) Cysteine proteases of
parasitic organisms. Mol Biochem Parasitol 120: 1–21.
Salmon, D., do Aido-Machado, R., Diehl, A., Leidert, M.,
Schmetzer, O., de, A.L.A., et al. (2006) Solution structure
and backbone dynamics of the Trypanosoma cruzi cysteine
protease inhibitor chagasin. J Mol Biol 357: 1511–1521.
Sanderson, S.J., Westrop, G.D., Scharfstein, J., Mottram,
J.C., and Coombs, G.H. (2003) Functional conservation of
a natural cysteine peptidase inhibitor in protozoan and
bacterial pathogens. FEBS Lett 542: 12–16.
Santos, C.C., Sant’Anna, C., Terres, A., Cunha-e-Silva, N.,
Scharfstein, J., and de, A.L. (2005) Chagasin, the endo-
genous cysteine protease inhibitor of Trypanosoma cruzi,
modulates parasite differentiation and invasion of mamma-
lian cells. J Cell Sci 118: 901–915.
Santos, C.C., Coombs, G.H., Lima, A.P.C.A., and Mottram,
J.C. (2007) Role of the Trypanosoma brucei natural
cysteine peptidase inhibitor ICP in differentiation and
virulence. Mol Microbiol 66: 991–1002.
Seong, I.S., Lee, H.R., Seol, J.H., Park, S.K., Lee, C.S., Suh,
S.W., et al. (1994) The P1 reactive site methionine residue
of ecotin is not crucial for its speciﬁcity on target proteases.
A potent inhibitor of pancreatic serine proteases from
Escherichia coli. J Biol Chem 269: 21915–21918.
Shin, D.H., Song, H.K., Seong, I.S., Lee, C.S., Chung, C.H.,
and Suh, S.W. (1996) Crystal structure analyses of uncom-
plexed ecotin in two crystal forms: implications for its func-
tion and stability. Protein Sci 5: 2236–2247.
Smith, B.O., Picken, N.C., Westrop, G.D., Bromek, K.,
Mottram, J.C., and Coombs, G.H. (2006) The structure of
Leishmania mexicana ICP provides evidence for conver-
gent evolution of cysteine peptidase inhibitors. J Biol Chem
281: 5821–5828.
Stoop, A.A., and Craik, C.S. (2003) Engineering of a macro-
molecular scaffold to develop speciﬁc protease inhibitors.
Nat Biotechnol 21: 1063–1068.
Talamas-Rohana, P., Wright, S.D., Lennartz, M.R., and
Russell, D.G. (1990) Lipophosphoglycan from Leishmania
mexicana promastigotes binds to members of the CR3,
p150,95 and LFA-1 family of leukocyte integrins. J Immunol
144: 4817–4824.
Van Zandbergen, G., Klinger, M., Mueller, A., Dannenberg,
S., Gebert, A., Solbach, W., et al. (2004) Cutting edge:
neutrophil granulocyte serves as a vector for Leishmania
entry into macrophages. J Immunol 173: 6521–6525.
Van Zandbergen, G., Bollinger, A., Wenzel, A., Kamhawi, S.,
Voll,R.,Klinger,M.,et al.(2006)Leishmaniadiseasedevel-
opment depends on the presence of apoptotic promas-
tigotes in the virulent inoculum. PNAS 103: 13837–13842.
Van Zandbergen, G., Solbach, W., and Laskay, T. (2007)
Apoptosis driven infection. Autoimmunity 40: 349–352.
Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J.,
Huang, F.P., et al. (1995) Altered immune responses in
mice lacking inducible nitric oxide synthase. Nature 375:
408–411.
Yang, S.Q., Wang, C.I., Gillmor, S.A., Fletterick, R.J., and
Craik, C.S. (1998) Ecotin: a serine protease inhibitor with
two distinct and interacting binding sites. J Mol Biol 279:
945–957.
120 S. C. P. Eschenlauer et al.
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Cellular Microbiology, 11, 106–120